HIGHLIGHTS OF THE SECOND QUARTER 2018
Sales revenue of the second quarter decreased by 2.6% (1% at constant rate) in comparison to the second quarter of 2017. This decrease is mainly due to a regression of activity in France, Italy and Romania and to a growth in Russia and in North America.
The establishment of Levallois-Perret was sold on June 6, 2018, generating a profit of € 6.2 million.
The company has bought back 831 309 own shares as of June 30, 2018 in accordance with the provisions of the program authorized by the Shareholders' Meeting of May 17, 2018.
Given the slowdown in activity, operating income for the first half of 2018 should be lower than in 2017. Consequently and in the event of a weak pathology at the end of the year, operating income for 2018 could be down compared to 2017.
We carry on the development of homeopathy in the world with the same confidence and the same determination.
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer